Health & Fitness, Fitness Equipment

Selpercatinib is the first drug from Loxo's pipeline that Lilly has brought to market.Prior to the acquisition, Loxo won approval…

Although the company will continue to pursue "higher-risk, high reward" drug candidates such as pegilodecakin, these will be a…